Panacea Biotec Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA87-3
EBIT411,630
Earning Per Share-23175
Expenses548675
Net Profit-1481,078
Net Profit Margin-23163
Operating Profit Margin14-0
Profit Before Tax-1441,449
Dividends Per Share00
Operation Revenue635672

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Panacea Biotec is -3 as of 12/6/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212021
Operating Activities118105-30107107
Investing Activities55-5-35-48-48
Financing Activities-164-10191-47-47
Others00000
Net Cash Flow9-2261212

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Panacea Biotec is 107 as of 12/6/2023